CymitQuimica logo

CAS 62006-39-7

:

3-Butyl-4,5-dihydro-2-benzofuran-1(3H)-one

Description:
3-Butyl-4,5-dihydro-2-benzofuran-1(3H)-one, with the CAS number 62006-39-7, is an organic compound characterized by its unique bicyclic structure, which consists of a benzofuran moiety. This compound features a butyl group attached to the benzofuran ring, contributing to its hydrophobic properties. It is typically a colorless to pale yellow liquid or solid, depending on its purity and specific conditions. The presence of the carbonyl group in the lactone structure imparts reactivity, making it susceptible to nucleophilic attack and other chemical transformations. This compound may exhibit biological activity, which can be of interest in medicinal chemistry and natural product synthesis. Its solubility in organic solvents and limited solubility in water are typical for compounds of this class, influencing its applications in various fields, including pharmaceuticals and agrochemicals. Safety data should be consulted for handling and usage, as with any chemical substance.
Formula:C12H16O2
InChI:InChI=1/C12H16O2/c1-2-3-8-11-9-6-4-5-7-10(9)12(13)14-11/h5,7,11H,2-4,6,8H2,1H3
SMILES:CCCCC1C2=C(C=CCC2)C(=O)O1
Synonyms:
  • 1(3H)-isobenzofuranone, 3-butyl-4,5-dihydro-
  • 3-N-butyl-4,5-dihydrophthalide
Sort by

Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 1 products.
  • Senkyunolide A

    CAS:
    Senkyunolide A is a p-glycoprotein (P-gp) inhibitor that has been shown to be effective in treating injuries. Senkyunolide A binds to P-gp and prevents the efflux of anticancer drugs or chemotherapeutic agents from tumor tissue, thus increasing the concentration of these drugs at the site of injury. Senkyunolide A has also been found to be an effective inhibitor of matrix metalloproteinases (MMPs), which are enzymes that degrade the extracellular matrix, leading to cell death. The effect on MMPs is due to senkyunolide's ability to bind to the active site of MMPs and inhibit their catalytic activity. This compound has been shown in vitro to inhibit neuronal death caused by oxygen deprivation and may have use for preventing cerebral injury, such as stroke. Senkyunolide A has been shown in vitro to be an effective inhibitor of polymerase chain reaction (PC
    Formula:C12H16O2
    Purity:Min. 95%
    Molecular weight:192.25 g/mol

    Ref: 3D-MCA00639

    50mg
    814.00€
    100mg
    1,228.00€